|
1)
Imatinib treatment inhibits IL-6, IL-8, NF-KB and
AP-1 production and modulate intracellular calcium in CML patients.
Ciarcia R, Vitiello MT, Galdiero M, Pacilio C,
Iovane V, d'Angelo D, Pagnini D, Caparrotti G, Conti D, Tomei V,
Florio S, Giordano A.
J Cell
Physiol. 2011 Sep 21
2)
New pyrazolo[3,4-d]pyrimidine SRC inhibitors
induce apoptosis in mesothelioma cell lines through p27 nuclear
stabilization.
Indovina P, Giorgi F, Rizzo V, Khadang B,
Schenone S, Di Marzo D, Forte IM, Tomei V, Mattioli E, D'Urso
V, Grilli B, Botta M, Giordano A, Pentimalli F.
Oncogene.
2011 Jul 25
3)
Aromatase and 5-alpha reductase gene expression:
modulation by pain and morphine treatment in male rats.
Aloisi AM, Ceccarelli I, Fiorenzani P,
Maddalena M, Rossi A, Tomei V, Sorda G, Danielli B, Rovini M,
Cappelli A, Anzini M, Giordano A.
Mol
Pain. 2010 Oct 26;6:69.
4)
Downregulation and aberrant promoter methylation
of p16INK4A: a possible novel heritable susceptibility marker to
retinoblastoma.
Indovina P, Acquaviva A, De Falco G, Rizzo V,
Onnis A, Luzzi A, Giorgi F, Hadjistilianou T, Toti P, Tomei V,
Pentimalli F, Carugi A, Giordano A.
J Cell
Physiol. 2010 Apr;223(1):143-50.
|